Does DHA Cross the Placenta? The Science

A baby’s brain grows at an exceptional rate before birth, particularly during the final trimester. DHA, or docosahexaenoic acid, is one of the major omega-3 fats incorporated into developing brain and retinal tissue. So, does DHA cross the placenta? Yes. DHA is transferred from the mother’s circulation to the fetus through the placenta, using a selective and carefully regulated biological system.

That answer is clear, but it does not mean transfer is automatic or identical in every pregnancy. Maternal diet, existing omega-3 status, stage of pregnancy and placental function can all influence the amount of DHA available to the developing baby.

Does DHA cross the placenta selectively?

The placenta is not simply a passive filter. It is a living organ that manages the exchange of oxygen, nutrients and metabolic products between mother and fetus. For fatty acids, this involves several steps: fats must be released from circulating lipoproteins, taken up by placental cells, bound to transport proteins and then released towards the fetal circulation.

Research consistently shows that the fetus receives a relatively high proportion of long-chain polyunsaturated fatty acids, especially DHA and arachidonic acid. This is sometimes called preferential transfer. In practical terms, the concentration of DHA in fetal blood can be higher than would be expected from passive movement alone.

Several placental proteins appear to contribute, including fatty acid transport proteins, fatty acid binding proteins and a transporter known as MFSD2A. The precise contribution of each pathway is still being investigated, but the overall finding is well established: the placenta actively supports the delivery of DHA needed for development.

Why DHA matters during fetal development

DHA is a structural component of cell membranes. It is particularly concentrated in the brain and retina, where it helps membranes remain flexible and supports cell signalling. During late pregnancy, the fetal brain accumulates DHA rapidly. This creates a genuine nutritional demand at a time when the fetus depends largely on maternal supply.

Human studies associate higher maternal DHA status with measures of infant visual and neurodevelopment, although the outcomes are not uniform across every study. Development is influenced by many factors, including genetics, gestational age, overall maternal nutrition, home environment and health during pregnancy. DHA should therefore be understood as one necessary component of normal development, not a guarantee of a particular developmental outcome.

There is also evidence that low maternal omega-3 status may matter. Women who eat little or no seafood, or who begin pregnancy with low DHA stores, may have less DHA available for placental transfer. The body can make a limited amount of DHA from the plant omega-3 alpha-linolenic acid, but this conversion is generally inefficient and varies between individuals.

How maternal DHA reaches the baby

After a meal containing oily fish, seafood or a DHA supplement, dietary fats are absorbed in the intestine and enter the bloodstream within lipoprotein particles. DHA then circulates in several forms, including as part of triglycerides and phospholipids, or attached to albumin as a non-esterified fatty acid.

At the placenta, enzymes help release fatty acids from these circulating particles. DHA can then be taken into placental cells and directed across to the fetal side. Some DHA may be used by the placenta itself, while the remainder is available for transfer.

This system becomes especially relevant in the third trimester, when fetal fat stores, brain tissue and retinal tissue are developing quickly. A mother’s DHA status earlier in pregnancy still matters, however, because it contributes to the pool of omega-3 available throughout gestation.

Maternal blood DHA does not map perfectly onto fetal exposure. Placental biology can modify the relationship, and certain health conditions may affect nutrient transport. Even so, randomised trials show that maternal DHA supplementation generally raises DHA concentrations in maternal and cord blood. This supports the biological evidence that improving maternal DHA availability can increase delivery to the fetus.

What affects placental DHA transfer?

The first factor is maternal intake and status. Regular consumption of low-mercury oily fish is a meaningful source of preformed DHA. People who avoid fish may obtain DHA from algae-based supplements, which provide the same DHA molecule without relying on fish consumption.

The form in which DHA is consumed may affect absorption, particularly when supplements are taken with a meal containing fat. Yet for pregnancy nutrition, the total absorbed DHA and sustained maternal status are usually more relevant than broad claims about one format being universally superior. Supplement quality also matters: oxidation, freshness and verified purity are practical considerations when choosing a marine oil.

Gestational age is another factor. Placental expression of fatty acid transport mechanisms changes over pregnancy, consistent with increased fetal demand later on. Maternal stores may also be important when dietary intake is inconsistent.

Health conditions can complicate the picture. Obesity, gestational diabetes, pre-eclampsia and placental dysfunction have each been associated in some research with alterations in fatty acid metabolism or transport. These findings do not mean that DHA supplementation can correct a medical condition. They do reinforce why individual dietary advice in higher-risk pregnancies should be discussed with a midwife, obstetrician or registered dietitian.

How much DHA is appropriate in pregnancy?

Guidance differs slightly between authorities, partly because studies have used different dietary assessments and supplement doses. The European Food Safety Authority considers an additional 100 mg of DHA per day, on top of the adult adequate intake of 250 mg per day of EPA plus DHA, appropriate during pregnancy and lactation.

In the UK, pregnancy advice also encourages fish consumption while setting limits for species that can contain higher levels of mercury or other contaminants. Two portions of fish per week, including one portion of oily fish, is a common practical benchmark. Women who are pregnant, trying to conceive or breastfeeding are advised not to eat more than two portions of oily fish weekly and to avoid shark, marlin and swordfish.

For people who do not eat fish, a DHA supplement can help bridge the gap. A supplement is not a substitute for an otherwise adequate diet, and more is not necessarily better. Doses used in clinical research vary, often from around 200 mg to 1,000 mg of DHA daily. The right approach depends on dietary intake, personal health and advice from a healthcare professional.

When selecting a fish oil, krill oil or algae-based product during pregnancy, look beyond the front-label omega-3 number. The stated DHA amount per daily serving should be clear. Products should also provide evidence of contaminant control and oxidation management. Fish and marine oils can accumulate oxidation products if poorly manufactured or stored, which is why sourcing, purification, packaging and freshness testing deserve attention.

Questions that often cause confusion

Can the baby make its own DHA?

The fetus has some ability to convert precursor fats into DHA, but this is limited. Placental transfer of maternal preformed DHA is therefore considered an important source, particularly in late pregnancy.

Does taking DHA guarantee better cognitive outcomes?

No. DHA supports normal biological development, but cognition cannot be reduced to a single nutrient. Trial results on later childhood cognitive testing are mixed, even where maternal and infant DHA status improves. The evidence is stronger for DHA’s role as a structural nutrient and for its accumulation in the fetal brain and retina than for promises about intelligence.

Is fish always preferable to a supplement?

Fish offers protein, iodine, selenium and other nutrients alongside DHA, so it can be a valuable part of a balanced pregnancy diet. A well-made DHA supplement may be useful where fish intake is low, dietary preferences exclude seafood, or intake is inconsistent. The safest choice depends on the type and quantity of fish eaten, as well as individual circumstances.

The placental transfer of DHA is an elegant example of maternal nutrition serving fetal development. Rather than pursuing a single perfect number, aim for a reliable, safe source of DHA within a balanced pregnancy diet, and seek personalised guidance whenever pregnancy care or medical history calls for it.